These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1384970)

  • 1. Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
    Kuno S; Mizuta E; Nishida J; Takechi M
    Clin Neuropharmacol; 1992 Oct; 15(5):381-6. PubMed ID: 1384970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.
    Emborg ME; Tetrud JW; Moirano J; McLaughlin WW; Bankiewicz KS
    Front Biosci; 2003 May; 8():a148-54. PubMed ID: 12700090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
    Degryse AD; Colpaert FC
    Brain Res Bull; 1986 May; 16(5):561-71. PubMed ID: 3488798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of essential tremor with arotinolol.
    Kuroda Y; Kakigi R; Shibasaki H
    Neurology; 1988 Apr; 38(4):650-2. PubMed ID: 2451192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(1):43-7. PubMed ID: 1348351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiology of MPTP tremor.
    Bergman H; Raz A; Feingold A; Nini A; Nelken I; Hansel D; Ben-Pazi H; Reches A
    Mov Disord; 1998; 13 Suppl 3():29-34. PubMed ID: 9827591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational physiology of the basal ganglia in Parkinson's disease.
    Rivlin-Etzion M; Elias S; Heimer G; Bergman H
    Prog Brain Res; 2010; 183():259-73. PubMed ID: 20696324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an alpha 2 antagonist in a 20-year-old Java monkey with MPTP-induced parkinsonian signs.
    Colpaert FC; Degryse AD; Van Craenendonck HV
    Brain Res Bull; 1991 Apr; 26(4):627-31. PubMed ID: 1678307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Clin Neuropharmacol; 1991 Aug; 14(4):359-66. PubMed ID: 1913702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ethosuximide on rest tremor in the MPTP monkey model.
    Gomez-Mancilla B; Latulippe JF; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(2):137-41. PubMed ID: 1350061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
    Wolters EC; Kebabian JC; Guttman M; Mak E; Pate BD; Calne DB
    Neurosci Lett; 1988 Dec; 95(1-3):257-61. PubMed ID: 3265771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model.
    Bezard E; Stutzmann JM; Imbert C; Boraud T; Boireau A; Gross CE
    Eur J Pharmacol; 1998 Sep; 356(2-3):101-4. PubMed ID: 9774238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor.
    Lee KS; Kim JS; Kim JW; Lee WY; Jeon BS; Kim D
    Parkinsonism Relat Disord; 2003 Aug; 9(6):341-7. PubMed ID: 12853233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
    Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC
    Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Close SP; Marriott AS; Pay S
    Br J Pharmacol; 1985 Jun; 85(2):320-2. PubMed ID: 3928007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of levodopa-induced dyskinesias in parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms.
    Schneider JS; Gonczi H; Decamp E
    Brain Res; 2003 Nov; 990(1-2):38-44. PubMed ID: 14568327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.
    Battino M; Littarru GP; Gorini A; Villa RF
    Neurochem Res; 1996 Dec; 21(12):1505-14. PubMed ID: 8953566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.